NON VALVULAR ATRIAL FIBRILLATION
Clinical trials for NON VALVULAR ATRIAL FIBRILLATION explained in plain language.
Never miss a new study
Get alerted when new NON VALVULAR ATRIAL FIBRILLATION trials appear
Sign up with your email to follow new studies for NON VALVULAR ATRIAL FIBRILLATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart device could help AFib patients ditch blood thinners
Disease control OngoingThis study is testing a device called the Omega™ Left Atrial Appendage Occluder in 200 people with non-valvular atrial fibrillation (an irregular heartbeat) who are at high risk for both stroke and bleeding. The device is placed through a small tube in a blood vessel to close off…
Matched conditions: NON VALVULAR ATRIAL FIBRILLATION
Phase: NA • Sponsor: Eclipse Medical Ltd. • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New heart device aims to cut stroke risk in AFib patients
Disease control TerminatedThis study compares a new device (Laminar LAAC) to existing ones for closing a small heart pouch (left atrial appendage) in 1500 people with non-valvular atrial fibrillation. The goal is to reduce the risk of stroke and blood clots without needing long-term blood thinners. Partic…
Matched conditions: NON VALVULAR ATRIAL FIBRILLATION
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New device could help AFib patients ditch blood thinners
Disease control OngoingThis early study tests a new device that closes off a small pouch in the heart (the left atrial appendage) in people with atrial fibrillation who cannot take blood thinners. The goal is to reduce the risk of stroke without needing lifelong medication. About 45 participants will b…
Matched conditions: NON VALVULAR ATRIAL FIBRILLATION
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC